CHARACTERIZATION OF ANTICYTOKINE AUTOANTIBODIES IN INTRAVENOUS IMMUNOGLOBULIN (IVIG) PREPARATIONS

被引：0
|
作者：
Rosen, Lindsey B. [1 ]
Glowinski, Rebecca M. [1 ]
Berger, Melvin [2 ]
Browne, Sarah K. [3 ]
Holland, Steven M. [1 ]
机构：
[1] NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] CSL Behring LLC, Immunol R&D, King Of Prussia, PA USA
[3] US FDA, Silver Spring, MD USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2016年 / 36卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
4457
引用
收藏
页码：270 / 271
页数：2
相关论文
共 50 条
  • [41] INTRAVENOUS IMMUNOGLOBULIN (IVIG) THERAPY OF NEONATAL SEPSIS
    WEISMAN, LE
    STOLL, B
    KUESER, T
    RUBIO, T
    FRANK, G
    HEIMAN, H
    SUBRAMANIAN, S
    HANKINS, C
    HEMMING, V
    FISCHER, GW
    PEDIATRIC RESEARCH, 1990, 27 (04) : A277 - A277
  • [42] Intravenous immunoglobulin (IVIg) for the treatment of Alzheimer disease
    Relkin, Norman
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S55 - S55
  • [43] Basic principles of intravenous immunoglobulin (IVIg) treatment
    Stangel, Martin
    Pul, Refik
    JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 5) : 18 - 24
  • [44] Intravenous immunoglobulin (IVIG) for the treatment of antiphospholipid syndrome
    Heilmann, L
    Berg, C
    von Tempelhoff, GF
    Gehler, J
    Zimmer, B
    Wolf, H
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 1998, 202 (04): : 164 - 167
  • [45] Modulation of autoimmune responses by intravenous immunoglobulin (IVIg)
    Kaveri, S
    Prasad, N
    Vassilev, T
    Hurez, V
    Pashov, A
    LacroixDesmazes, S
    Kazatchkine, M
    MULTIPLE SCLEROSIS, 1997, 3 (02): : 121 - 128
  • [46] USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) THERAPY IN ADULTS
    HERROD, HG
    ALLERGY PROCEEDINGS, 1994, 15 (06): : 309 - 312
  • [47] Epitope-specific glutamic acid decarboxylase-65 autoantibodies in intravenous immunoglobulin preparations
    Hao, W
    Davis, C
    Daniels, T
    Hampe, CS
    Lernmark, Å
    TRANSFUSION MEDICINE, 1999, 9 (04) : 307 - 310
  • [48] Cellular mechanisms of action of intravenous immunoglobulin (IVIg) in reducing the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica
    Ratelade, J.
    Smith, A.
    Verkman, A. S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 208 - 209
  • [49] CHARACTERIZATION, STANDARDIZATION AND CONTROL OF THERAPEUTIC IMMUNOGLOBULIN PREPARATIONS INTENDED FOR INTRAVENOUS USE
    THORPE, R
    BIRD, CR
    BRASHER, MDR
    JOURNAL OF INFECTION, 1987, 15 : 13 - &
  • [50] Intravenous immunoglobulin (IVIG) in the vanguard therapy of Systemic Sclerosis
    Gomes, Joao Pedro
    Santos, Lelila
    Shoenfeld, Yehuda
    CLINICAL IMMUNOLOGY, 2019, 199 : 25 - 28
12345